Glioblastoma Multiform: Clinical Trials

1 trial for Glioblastoma Multiform, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Glioblastoma Multiform: new trials by email Literature Review of Glioblastoma Multiform trials Research Report on Glioblastoma Multiform

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
TLX-101-Tx + Lomustine, TLX101-Tx - Neoplastic Disease, Glioblastoma
Phase 3RecruitingTelix Pharmaceuticals (Innovations) Pty Limited512025-11-022026-11-16

Narrower conditions

Brain Neoplasms (1)  ·  Central Nervous System Neoplasms (1)  ·  Glioblastoma (1)  ·  Neoplasm Recurrence, Local (1)  ·  Neoplasms (1)

Broader conditions

Astrocytoma (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Glioma (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neoplastic Processes (1)  ·  Nervous System Diseases (1)  ·  Nervous System Neoplasms (1)  ·  Neuroectodermal Tumors (1)  ·  Pathologic Processes (1)

Interventions

Lomustine (1)

Sponsors

Telix Pharmaceuticals (Innovations) Pty Limited (1)

Countries

Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Netherlands (1)

NIH funding

2025 (1)